OXFORD CANNABINOID TECHNOLOGIES LTD

Company Registration Number:
10664635 (England and Wales)

Unaudited statutory accounts for the year ended 30 June 2024

Period of accounts

Start date: 1 May 2023

End date: 30 June 2024

OXFORD CANNABINOID TECHNOLOGIES LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

OXFORD CANNABINOID TECHNOLOGIES LTD

Directors' report period ended 30 June 2024

The directors present their report with the financial statements of the company for the period ended 30 June 2024

Principal activities of the company

The principal activity of the Company is to support the Group’s research, and ultimately the development and commercialisation, of a range of cannabinoid-based prescription medication targeting the pain market.



Directors

The directors shown below have held office during the whole of the period from
1 May 2023 to 30 June 2024

Paul Smalley
Clarissa Sowemimo-Coker
Neil Mahapatra


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
25 November 2024

And signed on behalf of the board by:
Name: Paul Smalley
Status: Director

OXFORD CANNABINOID TECHNOLOGIES LTD

Profit And Loss Account

for the Period Ended 30 June 2024

14 months to 30 June 2024 2023


£

£
Turnover: 0 0
Cost of sales: 0 0
Gross profit(or loss): 0 0
Administrative expenses: ( 12,877 ) ( 15,209 )
Operating profit(or loss): (12,877) (15,209)
Interest receivable and similar income: 2,104 3,837
Profit(or loss) before tax: (10,773) (11,372)
Profit(or loss) for the financial year: (10,773) (11,372)

OXFORD CANNABINOID TECHNOLOGIES LTD

Balance sheet

As at 30 June 2024

Notes 14 months to 30 June 2024 2023


£

£
Current assets
Cash at bank and in hand: 10,861 2,192,774
Total current assets: 10,861 2,192,774
Prepayments and accrued income: 10 35,286
Creditors: amounts falling due within one year: 3 ( 711,345 ) ( 2,917,761 )
Net current assets (liabilities): (700,474) (689,701)
Total assets less current liabilities: (700,474) ( 689,701)
Total net assets (liabilities): (700,474) (689,701)
Capital and reserves
Called up share capital: 196 196
Share premium account: 6,947,413 6,947,413
Other reserves: 1,058,544 1,058,544
Profit and loss account: (8,706,627 ) (8,695,854 )
Total Shareholders' funds: ( 700,474 ) (689,701)

The notes form part of these financial statements

OXFORD CANNABINOID TECHNOLOGIES LTD

Balance sheet statements

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 25 November 2024
and signed on behalf of the board by:

Name: Paul Smalley
Status: Director

The notes form part of these financial statements

OXFORD CANNABINOID TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

    Intangible fixed assets amortisation policy

    Intangible assets are stated at cost less amortisation and are reviewed for impairment whenever there is an indication that the carrying value may be impaired

OXFORD CANNABINOID TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 2. Employees

    14 months to 30 June 2024 2023
    Average number of employees during the period 0 0

OXFORD CANNABINOID TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

3. Creditors: amounts falling due within one year note

14 months to 30 June 2024 2023
£ £
Other creditors 711,345 2,917,761
Total 711,345 2,917,761